| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.008 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |